Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 IDH1 and IDH2 mutations in myeloid neoplasms--novel paradigms and clinical implications.

Literature DB >> 20884716

IDH1 and IDH2 mutations in myeloid neoplasms--novel paradigms and clinical implications.

Mario Cazzola.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 2010 PMID： 20884716 PMCID： PMC2948084 DOI： 10.3324/haematol.2010.030015

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 11.047

× No keyword cloud information.

31 in total

1. Metabolism, gliomas, and IDH1.

Authors: Jan Smeitink
Journal: N Engl J Med Date: 2010-03-25 Impact factor: 91.245

2. Deletions of the transcription factor Ikaros in myeloproliferative neoplasms.

Authors: R Jäger; H Gisslinger; F Passamonti; E Rumi; T Berg; B Gisslinger; D Pietra; A Harutyunyan; T Klampfl; D Olcaydu; M Cazzola; R Kralovics
Journal: Leukemia Date: 2010-05-27 Impact factor: 11.528

3. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.

Authors: J Boultwood; J Perry; A Pellagatti; M Fernandez-Mercado; C Fernandez-Santamaria; M J Calasanz; M J Larrayoz; M Garcia-Delgado; A Giagounidis; L Malcovati; M G Della Porta; M Jädersten; S Killick; E Hellström-Lindberg; M Cazzola; J S Wainscoat
Journal: Leukemia Date: 2010-02-25 Impact factor: 11.528

4. Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.

Authors: Gorica Nikoloski; Saskia M C Langemeijer; Roland P Kuiper; Ruth Knops; Marion Massop; Evelyn R L T M Tönnissen; Adrian van der Heijden; Theresia N Scheele; Peter Vandenberghe; Theo de Witte; Bert A van der Reijden; Joop H Jansen
Journal: Nat Genet Date: 2010-07-04 Impact factor: 38.330

5. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations.

Authors: Stefan Gross; Rob A Cairns; Mark D Minden; Edward M Driggers; Mark A Bittinger; Hyun Gyung Jang; Masato Sasaki; Shengfang Jin; David P Schenkein; Shinsan M Su; Lenny Dang; Valeria R Fantin; Tak W Mak
Journal: J Exp Med Date: 2010-02-08 Impact factor: 17.579

6. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate.

Authors: Lenny Dang; David W White; Stefan Gross; Bryson D Bennett; Mark A Bittinger; Edward M Driggers; Valeria R Fantin; Hyun Gyung Jang; Shengfang Jin; Marie C Keenan; Kevin M Marks; Robert M Prins; Patrick S Ward; Katharine E Yen; Linda M Liau; Joshua D Rabinowitz; Lewis C Cantley; Craig B Thompson; Matthew G Vander Heiden; Shinsan M Su
Journal: Nature Date: 2009-12-10 Impact factor: 49.962

7. An integrated genomic analysis of human glioblastoma multiforme.

Authors: D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal: Science Date: 2008-09-04 Impact factor: 47.728

8. IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.

Authors: A Pardanani; T L Lasho; C M Finke; M Mai; R F McClure; A Tefferi
Journal: Leukemia Date: 2010-04-22 Impact factor: 12.883

9. Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.

Authors: Saman Abbas; Sanne Lugthart; François G Kavelaars; Anita Schelen; Jasper E Koenders; Annelieke Zeilemaker; Wim J L van Putten; Anita W Rijneveld; Bob Löwenberg; Peter J M Valk
Journal: Blood Date: 2010-06-10 Impact factor: 25.476

10. Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms.

Authors: Anthony Green; Philip Beer
Journal: N Engl J Med Date: 2010-01-28 Impact factor: 176.079

9 in total

1. Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Authors: Mario Cazzola
Journal: Haematologica Date: 2011-03 Impact factor: 9.941

2. Cytogenetic risk stratification in chronic myelomonocytic leukemia.

Authors: Esperanza Such; José Cervera; Dolors Costa; Francesc Solé; Teresa Vallespí; Elisa Luño; Rosa Collado; María J Calasanz; Jesús M Hernández-Rivas; Juan C Cigudosa; Benet Nomdedeu; Mar Mallo; Felix Carbonell; Javier Bueno; María T Ardanaz; Fernando Ramos; Mar Tormo; Reyes Sancho-Tello; Consuelo del Cañizo; Valle Gómez; Victor Marco; Blanca Xicoy; Santiago Bonanad; Carmen Pedro; Teresa Bernal; Guillermo F Sanz
Journal: Haematologica Date: 2010-11-25 Impact factor: 9.941

3. Detection of mutations in myeloid malignancies through paired-sample analysis of microdroplet-PCR deep sequencing data.

Authors: Donavan T Cheng; Janice Cheng; Talia N Mitchell; Aijazuddin Syed; Ahmet Zehir; Nana Yaa T Mensah; Alifya Oultache; Khedoudja Nafa; Ross L Levine; Maria E Arcila; Michael F Berger; Cyrus V Hedvat
Journal: J Mol Diagn Date: 2014-07-10 Impact factor: 5.568

4. Myeloproliferative neoplasms: from JAK2 mutations discovery to JAK2 inhibitor therapies.

Authors: Francesco Passamonti; Margherita Maffioli; Domenica Caramazza; Mario Cazzola
Journal: Oncotarget Date: 2011-06

Review 5. Bridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas.

Authors: Ourania Romanidou; Vassiliki Kotoula; George Fountzilas
Journal: Cancer Genomics Proteomics Date: 2018 Sep-Oct Impact factor: 3.395

6. Loss of 5-Hydroxymethylcytosine Is an Independent Unfavorable Prognostic Factor for Esophageal Squamous Cell Carcinoma.

Authors: Xuejiao Shi; Yue Yu; Mei Luo; Zhirong Zhang; Susheng Shi; Xiaoli Feng; Zhaoli Chen; Jie He
Journal: PLoS One Date: 2016-04-06 Impact factor: 3.240